LD-2 disclosure · 3rd Quarter - Report
VIR BIOTECHNOLOGY, INC.
via VIR BIOTECHNOLOGY, INC.
Client
- Name
- VIR BIOTECHNOLOGY, INC.
- Location
- California · United States of America
Registrant
- Firm
- VIR BIOTECHNOLOGY, INC.
- Description
- Commercial-stage immunology company
- Location
- San Francisco, California, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Reimbursement of COVID-19 Therapeutics
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Science & Technology Policy (OSTP) · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)
Science/Technology
Pandemic Preparedness
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Science & Technology Policy (OSTP) · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)
Health Issues
S. 2640, Disease X Act; H.Res. 601, FY 2022 Budget Resolution and Reconciliation Instructions, S. Con. Res. 14 FY 2022 Budget Resolution and Reconciliation Instructions; Prescription Policy in Budget Reconciliation; American Rescue Plan Implementation (COVID-19 Response and COVID Therapeutics Procurements), Pandemic Preparedness.
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Science & Technology Policy (OSTP) · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)